We are live on ! Find out more
AIP

Ameritas Investment Partners Portfolio holdings

AUM $3.75B
1-Year Est. Return 46.53%
This Fund
S&P 500
This Quarter Est. Return
+7.62%
1 Year Est. Return
+46.53%
3 Year Est. Return
+120.27%
5 Year Est. Return
+150.66%
10 Year Est. Return
+646.21%
AUM
$2.79B
AUM Growth
+$164M
Cap. Flow
-$30.9M
Cap. Flow %
-1.11%
Top 10 Hldgs %
20.45%
Holding
3,380
New
284
Increased
506
Reduced
861
Closed
334

Top Buys

Rank Stock Value
1
AFL icon
Aflac
AFL
+$2.88M
2
AZPN
ASPEN TECHNOLOGY INC
AZPN
+$2.53M
3
TRGP icon
Targa Resources
TRGP
+$2.39M
4
UNP icon
Union Pacific
UNP
+$2.39M
5
G icon
Genpact
G
+$2.13M

Top Sells

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$5.13M
2
XLF icon
State Street Financial Select Sector SPDR ETF
XLF
+$3.96M
3
IJH icon
iShares Core S&P Mid-Cap ETF
IJH
+$3.79M
4
PTC icon
PTC
PTC
+$3.74M
5
KSU
Kansas City Southern
KSU
+$3.63M

Sector Composition

Rank Sector Weight
1 Technology 17.33%
2 Financials 10.82%
3 Consumer Discretionary 10.62%
4 Healthcare 9.9%
5 Industrials 9.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MPX
2876
DELISTED
Marine Products Corp
MPX
$13K ﹤0.01%
813
– –
NPCE icon
2877
Neuropace
NPCE
$500M
$13K ﹤0.01%
+546
New +$12.7K
SMMT icon
2878
Summit Therapeutics
SMMT
$11.2B
$13K ﹤0.01%
+1,762
New +$11.6K
XGN icon
2879
Exagen
XGN
$160M
$13K ﹤0.01%
849
+564
+198% +$8.65K
SMED
2880
DELISTED
Sharps Compliance Corp
SMED
$13K ﹤0.01%
1,261
– –
AFCG
2881
AFC Gamma
AFCG
$64.3M
$12K ﹤0.01%
+831
New +$12.8K
AKYA
2882
DELISTED
Akoya BioSciences
AKYA
$12K ﹤0.01%
+599
New +$12.4K
BRT
2883
BRT Apartments
BRT
$268M
$12K ﹤0.01%
682
– –
DWX icon
2884
State Street SPDR S&P International Dividend ETF
DWX
$529M
$12K ﹤0.01%
322
– –
FULC icon
2885
Fulcrum Therapeutics
FULC
$283M
$12K ﹤0.01%
1,100
– –
ICLN icon
2886
iShares Global Clean Energy ETF
ICLN
$2.11B
$12K ﹤0.01%
550
– –
INZY
2887
DELISTED
Inozyme Pharma
INZY
$12K ﹤0.01%
692
– –
KZR
2888
DELISTED
Kezar Life Sciences
KZR
$12K ﹤0.01%
224
– –
VRCA icon
2889
Verrica Pharmaceuticals
VRCA
$83.5M
$12K ﹤0.01%
108
– –
TLIS
2890
DELISTED
Talis Biomedical Corporation Common Stock
TLIS
$12K ﹤0.01%
72
– –
BLV icon
2891
Vanguard Long-Term Bond ETF
BLV
$5.73B
$11K ﹤0.01%
112
+1
+0.9% +$100
BMEA icon
2892
Biomea Fusion
BMEA
$92.8M
$11K ﹤0.01%
+677
New +$12K
BVS icon
2893
Bioventus
BVS
$1.17B
$11K ﹤0.01%
624
– –
CBNK icon
2894
Capital Bancorp
CBNK
$617M
$11K ﹤0.01%
525
– –
CTOS icon
2895
Custom Truck One Source
CTOS
$2.46B
$11K ﹤0.01%
1,171
– –
EEX
2896
DELISTED
Emerald Holding
EEX
$11K ﹤0.01%
2,053
– –
GWRS icon
2897
Global Water Resources
GWRS
$219M
$11K ﹤0.01%
641
– –
IGSB icon
2898
iShares 1-5 Year Investment Grade Corporate Bond ETF
IGSB
$23.4B
$11K ﹤0.01%
210
-100
-32% -$5.48K
IRON icon
2899
Disc Medicine
IRON
$3.07B
$11K ﹤0.01%
+57
New +$18.7K
KRUS icon
2900
Kura Sushi USA
KRUS
$637M
$11K ﹤0.01%
280
– –
114 115
116
117 118

Similar funds

DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
BCL
Bracebridge Capital LLC Boston, Massachusetts $3.73B AUM 33.02% 1-Year Est. Return
GCC
Guardian Capital (Canada) Toronto, Ontario, Canada $3.78B AUM 33.04% 1-Year Est. Return
SB
SIG Brokerage New York $3.79B AUM 44.46% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
AFI
American Family Investments Madison, Wisconsin $3.8B AUM 0.71% 1-Year Est. Return
CI
Cavalier Investments Alpharetta, Georgia $3.7B AUM 51.42% 1-Year Est. Return
TCIM
TOMS Capital Investment Management New York $3.81B AUM 26.36% 1-Year Est. Return

Ameritas Investment Partners's Q2 2021 Portfolio in Review

As of Q2 2021, Ameritas Investment Partners held 3,380 positions worth $2.79B, up 6.2% from $2.62B the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Ameritas Investment Partners's Q2 2021 filing shows 284 new, 506 increased, 861 reduced and 334 closed positions. Its largest new stake was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M. The largest sale was Charles River Laboratories, an estimated $5.13M.

By sector, the portfolio is most concentrated in Technology at 17% of assets, up from 17% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Ameritas Investment Partners's largest Q2 2021 buy was ASPEN TECHNOLOGY INC: 18,384 shares worth $2.53M.
  • Ameritas Investment Partners added most to Aflac in Q2 2021, an estimated $2.88M increase.
  • Ameritas Investment Partners's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $5.13M.
  • Ameritas Investment Partners fully exited TCF Financial Corporation Common Stock in Q2 2021, selling an estimated $1.96M.
  • Ameritas Investment Partners's ten largest holdings make up 20% of its $2.79B portfolio in Q2 2021.
  • Ameritas Investment Partners opened 284 new positions and closed 334 in Q2 2021.
  • Ameritas Investment Partners's portfolio value rose 6.2% quarter-over-quarter to $2.79B.

Based on Ameritas Investment Partners's 13F filing for Q2 2021, filed 6 Aug 2021.